Xwell (XWEL) Liabilities and Shareholders Equity (2010 - 2026)
Xwell's (XWEL) quarterly Liabilities and Shareholders Equity came in at $25.0 million in Q1 2026, up 0.66% year-on-year from $24.8 million in Q1 2025, and up 122.8% quarter-over-quarter from $11.2 million in Q4 2025.
Xwell (XWEL) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Xwell has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $25.0 million for Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $25.0 million, up 0.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $80.4 million (down 33.14% YoY), and the FY2025 annual result was $11.2 million, down 55.75% from the prior year.
- Liabilities and Shareholders Equity came in at $25.0 million for Q1 2026 at Xwell, up from $11.2 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $101.4 million in Q2 2022 to a low of $11.2 million in Q4 2025.
- The 5-year median for Liabilities and Shareholders Equity is $37.5 million (2024), against an average of $45.1 million.
- Across the five-year window, Liabilities and Shareholders Equity slumped 55.75% in 2025 and advanced 0.66% in 2026, its largest moves.
- Xwell's Liabilities and Shareholders Equity stood at $70.4 million in 2022, then slumped by 44.63% to $39.0 million in 2023, then plunged by 34.98% to $25.4 million in 2024, then tumbled by 55.75% to $11.2 million in 2025, then surged by 122.8% to $25.0 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $25.0 million (Q1 2026), $11.2 million (Q4 2025), and $21.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | 13.07 Bn |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | 29.68 Bn |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | 2.61 Bn |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Xwell | 9.25 Mn | 2.13 Mn | 2.35 Mn | 24.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.99 Mn |
| Dec 31, 2025 | 11.22 Mn |
| Sep 30, 2025 | 21.74 Mn |
| Jun 30, 2025 | 22.45 Mn |
| Mar 31, 2025 | 24.83 Mn |
| Dec 31, 2024 | 25.35 Mn |
| Sep 30, 2024 | 33.79 Mn |
| Jun 30, 2024 | 36.29 Mn |
| Mar 31, 2024 | 37.48 Mn |
| Dec 31, 2023 | 38.99 Mn |
| Sep 30, 2023 | 42.94 Mn |
| Jun 30, 2023 | 56.59 Mn |
| Mar 31, 2023 | 62.60 Mn |
| Dec 31, 2022 | 70.43 Mn |
| Sep 30, 2022 | 84.98 Mn |
| Jun 30, 2022 | 101.37 Mn |
| Mar 31, 2022 | 70.43 Mn |
| Dec 31, 2021 | 127.27 Mn |
| Sep 30, 2021 | 129.28 Mn |
| Jun 30, 2021 | 120.12 Mn |